Developing MCO-010 for Retinal Degenerative DiseasesBySamarendra Mohanty, PhDSeptember 10th 2021Samarendra Mohanty, PhD, cofounder and president, Nanoscope Therapeutics, discussed the company’s technological platforms and RESTORE trial data.